miércoles, 5 de enero de 2022

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

No hay comentarios:

Publicar un comentario